BEAM Beam Therapeutics Inc.
$21.01
Beam Therapeutics Inc. (BEAM) Earnings News
Earnings press releases, previews and reviews for Beam Therapeutics Inc. (BEAM), newest first.
Tuesday
November 3, 2026
7:00 AM ET
Beam Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Clinical Progress Across Base Editing Portfolio
Tuesday
August 4, 2026
7:00 AM ET
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)